Drug Patent Expirations for the Week of February 25, 2024

DYMISTA (azelastine hydrochloride; fluticasone propionate) Mylan speciality lp Patent: 8,163,723 Expiration: Feb 29, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence…
The post Drug Pate…


New patent for Pfizer drug VELSIPITY

Annual Drug Patent Expirations for VELSIPITY Velsipity is a drug marketed by Pfizer and is included in one NDA. It is available from two suppliers. There are six patents protecting…
The post New patent for Pfizer drug VELSIPITY appeared first on DrugPa…


Biotechblog